Výsledky vyhledávání - Jay Tibbitts
- Zobrazuji výsledky 1 - 10 z 10
-
1
-
2
-
3
A Mechanistic Pharmacokinetic Model Elucidating the Disposition of Trastuzumab Emtansine (T-DM1), an Antibody–Drug Conjugate (ADC) for Treatment of Metastatic Breast Cancer Autor Brendan C. Bender, Douglas D. Leipold, Keyang Xu, Ben‐Quan Shen, Jay Tibbitts, Lena E. Friberg
Vydáno 2014Artigo -
4
Semi-mechanistic Population Pharmacokinetic Model of Multivalent Trastuzumab Emtansine in Patients with Metastatic Breast Cancer Autor Vaishali L. Chudasama, Franziska Schaedeli Stark, John M. Harrold, Jay Tibbitts, Sandhya Girish, Manish Gupta, Norbert Frey, Donald E. Mager
Vydáno 2012Artigo -
5
Preclinical safety profile of trastuzumab emtansine (T-DM1): Mechanism of action of its cytotoxic component retained with improved tolerability Autor Kirsten Achilles Poon, Kelly M. Flagella, Joseph C. Beyer, Jay Tibbitts, Surinder Kaur, Ola M. Saad, Joo-Hee Yi, Sandhya Girish, Noël Dybdal, Theresa Reynolds
Vydáno 2013Artigo -
6
Antitumor Activity of Targeted and Cytotoxic Agents in Murine Subcutaneous Tumor Models Correlates with Clinical Response Autor Harvey Wong, Edna F. Choo, Bruno Alicke, Xiao Ding, Hank La, Erin McNamara, Frank‐Peter Theil, Jay Tibbitts, Lori S. Friedman, Cornelis E. C. A. Hop, Stephen E. Gould
Vydáno 2012Artigo -
7
The Effect of Different Linkers on Target Cell Catabolism and Pharmacokinetics/Pharmacodynamics of Trastuzumab Maytansinoid Conjugates Autor Hans K. Erickson, Gail D. Lewis Phillips, Douglas D. Leipold, Carmela A. Provenzano, Elaine Mai, Holly A. Johnson, Bert Gunter, Charlene A. Audette, Manish Gupta, Jan Pinkas, Jay Tibbitts
Vydáno 2012Artigo -
8
Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Autor Jagath R. Junutula, Kelly M. Flagella, Richard Graham, Kathryn L. Parsons, Edward Ha, Helga Raab, Sunil Bhakta, Trung Van Nguyen, Debra L. Dugger, Guangmin Li, Elaine Mai, Gail D. Lewis Phillips, Hajime Hiraragi, Reina N. Fuji, Jay Tibbitts, Richard Vandlen, Susan D. Spencer, Richard H. Scheller, Paul Polakis, Mark X. Sliwkowski
Vydáno 2010Artigo -
9
Multivalent Fcγ-receptor engagement by a hexameric Fc-fusion protein triggers Fcγ-receptor internalisation and modulation of Fcγ-receptor functions Autor Omar Qureshi, Tania F. Rowley, Fabian Junker, Shirley J. Peters, Siobhan Crilly, Joanne Compson, Alison Eddleston, Hanna Björkelund, Kevin Greenslade, Michael Parkinson, Nicola L. Davies, Patrick R. Griffin, Thomas L. Pither, Katharine Cain, Louis Christodoulou, Ludovicus Staelens, Emily Ward, Jay Tibbitts, Andrea Kießling, Bryan Smith, Frank R. Brennan, Magnus Malmqvist, Farnaz Fallah‐Arani, David P. Humphreys
Vydáno 2017Artigo -
10
Effects of Anti-VEGF on Pharmacokinetics, Biodistribution, and Tumor Penetration of Trastuzumab in a Preclinical Breast Cancer Model Autor Cinthia V. Pastuskovas, Eduardo E. Mundo, Simon P. Williams, Tapan K. Nayak, Jason Ho, Sheila Ulufatu, Suzanna Clark, Sarajane Ross, Fang-You Chen, Kathryn Parsons-Reponte, Gary A. Cain, Marjie Van Hoy, Nicholas Majidy, Sheila Bheddah, Josefa Chuh, Katherine R. Kozak, Nicholas Lewin‐Koh, Peter C. Nauka, Daniela Bumbaca, Mark X. Sliwkowski, Jay Tibbitts, Frank‐Peter Theil, Paul J. Fielder, Leslie A. Khawli, C. Andrew Boswell
Vydáno 2012Artigo
Vyhledávací nástroje:
Související témata
Medicine
Pharmacology
Biology
Immunology
Internal medicine
Breast cancer
Cancer
Chemistry
Pharmacokinetics
Trastuzumab
Antibody
Biochemistry
In vitro
Antibody-drug conjugate
Biotechnology
In vivo
Monoclonal antibody
Conjugate
Drug
Mathematical analysis
Mathematics
Oncology
Trastuzumab emtansine
Cell biology
Computer science
Cytotoxic T cell
Environmental health
Linker
Operating system
Pharmacodynamics